Join the Vitiligo group to help and get support from people like you.
Vitiligo News
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 – Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic skin diseases,...
Kids With Common Skin Conditions Face Stigma, Bullying
WEDNESDAY, April 24, 2024 – Acne, psoriasis, eczema, vitiligo, alopecia: Any one of these common skin ailments can render a child vulnerable to stigma and bullying at school, new research confirms....
Health Care Costs, Resource Utilization Increased for Vitiligo Patients
FRIDAY, Feb. 9, 2024 – Patients with vitiligo have significantly higher health care costs and health care resource utilization (HCRU), according to a study recently published in the Journal of...
Risk for Vitiligo Increased for Transplant Recipients
THURSDAY, Dec. 21, 2023 – Transplant recipients, especially those receiving hematopoietic stem cell transplant (HSCT), have an increased risk for vitiligo, according to a brief report published...
Half of Patients With Newly Diagnosed Vitiligo Do Not Receive Treatment
TUESDAY, Oct. 17, 2023 – A high proportion of patients with newly diagnosed vitiligo do not receive any treatment, according to a study recently published in Dermatology and Therapy. David Rosmarin,...
COVID Might Raise Odds for Immune Disorders Like Crohn's, Alopecia
TUESDAY, Oct. 10, 2023 – In rare cases, some patients may develop an autoimmune disease following a bout of COVID, Korean researchers report. Conditions such as alopecia (hair loss), psoriasis,...
Autoimmune, Autoinflammatory Connective Tissue Disorders Increased After COVID-19
TUESDAY, Oct. 10, 2023 – COVID-19 is associated with an increased risk for autoimmune and autoinflammatory connective tissue disorders, according to a study published online Oct. 6 in JAMA Network...
Reduced Mortality Risk Seen for Patients With Vitiligo
TUESDAY, Sept. 26, 2023 – Patients with vitiligo may have a reduced risk for mortality, according to a study published online Sept. 14 in the Journal of Investigative Dermatology. Hyun Jeong Ju,...
Incyte Announces U.S. FDA Approval of Opzelura (ruxolitinib) Cream for the Treatment of Vitiligo
Opzelura is the first and only FDA-approved product for repigmentation in nonsegmental vitiligo Phase 3 data supporting the approval show treatment with Opzelura resulted in improvements in facial...